Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin's disease. [electronic resource]
- Journal of neurology Sep 2006
- 1241-2 p. digital
Publication Type: Case Reports; Letter
0340-5354
10.1007/s00415-006-0171-6 doi
Antineoplastic Agents--therapeutic use Autoantibodies--metabolism Female Hodgkin Disease--therapy Humans Immunosuppressive Agents--therapeutic use Middle Aged Myasthenia Gravis--immunology Receptors, Cholinergic--immunology Thymectomy--methods